GoodRx Holdings, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
GoodRx Holdings, Inc. (GDRX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $54.60 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- GoodRx Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2023-06-30 was $55.90M.
- GoodRx Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $54.60M, a 0.00% change from fiscal 2023.
- GoodRx Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $54.60M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|
| 2024-12-31 | $54.60M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $54.60M 10-K · filed 2025-02-27 | |
| 2023-06-30 | $55.90M 10-Q · filed 2023-11-09 |